Latest News in the pharma Industry

Research & Development

Genentech’s Ocrelizumab Significantly Reduced Both Relapses and Disability Progression Versus Interferon Beta-1a in Two Phase III Studies

Genentech’s Ocrelizumab Significantly Reduced Both Relapses and Disability Progression Versus Interferon Beta-1a in Two Phase III Studies

30 Jun 2015

Read more 
Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma

Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma

29 Jun 2015

Read more 
Amarna Therapeutics Teaming Up with Austrian CBmed in the Development of Immunotherapies

Amarna Therapeutics Teaming Up with Austrian CBmed in the Development of Immunotherapies

29 Jun 2015

Read more 
Cyramza (Ramucirumab) Hepatocellular Carcinoma Data Published by The Lancet Oncology

Cyramza (Ramucirumab) Hepatocellular Carcinoma Data Published by The Lancet Oncology

23 Jun 2015

Read more 
Brain Inflammation Targeted in First Drug Discovery Project from £3m Dementia Consortium

Brain Inflammation Targeted in First Drug Discovery Project from £3m Dementia Consortium

22 Jun 2015

Read more 
Amgen Presents Open-Label Extension Data from Ongoing Phase II Study of AMG 334 In the Prevention of Episodic Migraine

Amgen Presents Open-Label Extension Data from Ongoing Phase II Study of AMG 334 In the Prevention of Episodic Migraine

22 Jun 2015

Read more 
Pharma R&D Pipeline Value Jumps 18% to $493 Billion, Drug Sales Forecast to Grow Nearly 5% Annually

Pharma R&D Pipeline Value Jumps 18% to $493 Billion, Drug Sales Forecast to Grow Nearly 5% Annually

19 Jun 2015

Read more 
Planned Development of QVM149 for Asthma

Planned Development of QVM149 for Asthma

18 Jun 2015

Read more 
New Tool Identifies Novel Compound Targeting Causes of Type 2 Diabetes

New Tool Identifies Novel Compound Targeting Causes of Type 2 Diabetes

18 Jun 2015

Read more 
New Biogen Hemophilia Data At ISTH Congress to Highlight Extension Study Outcomes and Pediatric Use

New Biogen Hemophilia Data At ISTH Congress to Highlight Extension Study Outcomes and Pediatric Use

18 Jun 2015

Read more 
Novartis Presents New Data from Large European Study Reinforcing the Benefit of First-Line Tasigna in Newly-Diagnosed Patients with CML

Novartis Presents New Data from Large European Study Reinforcing the Benefit of First-Line Tasigna in Newly-Diagnosed Patients with CML

17 Jun 2015

Read more 
Eli Lilly Enters Into Strategic Partnership with Sarah Cannon Research Institute to Develop Investigational Oncology Therapy

Eli Lilly Enters Into Strategic Partnership with Sarah Cannon Research Institute to Develop Investigational Oncology Therapy

17 Jun 2015

Read more